35.1 C
Delhi
Thursday, March 27, 2025

Tag: Oncology Portfolio

Merck Strengthens Oncology Portfolio Through Commercialization Agreement With Abbisko for Phase III Asset, Pimicotinib

Business Wire India Pimicotinib (ABSK021) is currently in a global Phase III study in tenosynovial giant cell tumor (TGCT) Merck to receive an exclusive...

- A word from our sponsors -

spot_img

Follow us

HomeTagsOncology Portfolio